Abbott Laboratories (ABT) Q1 2012 Earnings Call April 18, 2012 9:00 am ET Executives John B. Thomas - Vice President of Investor Relations & Public Affairs Thomas C. Freyman - Chief Financial Officer and Executive Vice President of Finance Larry Peepo - Analysts Frederick A. Wise - Leerink Swann LLC, Research Division Michael N. Weinstein - JP Morgan Chase & Co, Research Division Jami Rubin - Goldman Sachs Group Inc., Research Division David R. Lewis - Morgan Stanley, Research Division Glenn J. Novarro - RBC Capital Markets, LLC, Research Division Rajeev Jashnani - UBS Investment Bank, Research Division PresentationOperator
Good morning, and thank you for standing by. Welcome to Abbott's First Quarter 2012 Earnings Conference Call. [Operator Instructions] This call is being recorded by Abbott. With the exception of any participants' questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's expressed written permission. I would now like to introduce Mr. John Thomas, Vice President, Investor Relations and Public Affairs. John B. Thomas Good morning, and thanks for joining us. Also on today's call will be Tom Freyman, Executive Vice President, Finance and Chief Financial Officer; and Larry Peepo, Divisional Vice President of Investor Relations. Tom will review the details of our financial results for the quarter, as well as our outlook for the year. Larry and I will then discuss the highlights of our major businesses. Following our comments, we'll take any questions you may have, as always.